Company / Book Value per Share
Sonoma Pharmaceuticals, Inc. Book Value per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$7.864
FY2025
5-year range
$1.617 / $7.864
FY2021-FY2025
Trend
+386.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share changed +386% YoY in FY2025, a notable deviation from the 8-year average annual change of +83%.
Based on SEC 10-K filings.
$7.864 in FY2025 with a 5-year CAGR of -0.3%.
Improved from $2.805 to $7.864 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +45.3%
- 5-Year CAGR
- -0.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -0.3%, indicating a declining trend.
- In FY2025, book value per share increased 386.4% year-over-year.
- Peak book value per share was recorded in FY2019.
- Lowest book value per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | $7.864 | +386.4% |
| FY2024 | $1.617 | -42.3% |
| FY2023 | $2.805 | +9.5% |
| FY2022 | $2.562 | -19.0% |
| FY2021 | $3.164 | -60.3% |
| FY2020 | $7.968 | -64.3% |
| FY2019 | $22.349 | +347.3% |
| FY2018 | $4.996 | +106.8% |
| FY2017 | $2.416 | +201.6% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026